Search results
Author(s):
Rasha Al-Lamee
,
Christopher Rajkumar
,
Nazli Okumus
Added:
1 year ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA…
View more
Author(s):
Rasha Al-Lamee
,
Michael Foley
Added:
1 year ago
ACC.24 — Investigators, Dr Rasha K Al-Lamee and Dr Michael Foley (Imperial College London, UK) joined us to discuss the ORBITA COSMIC trial (NCT04892537).This randomized, double-blinded, placebo-controlled trial investigated the effects of coronary sinus reducer (CSR) as compared to placebo on myocardial perfusion via MRI, exercise duration, and symptoms in patients with refractory angina and…
View more
Carolyn M Webb
Author
Hiroaki Shimokawa
Job title: Professor and Chairman, Division of Cardiovascular Medicine
Author
Author(s):
Yetunde A Fatade
,
Noah A Newman
,
Nidhi H Patel
,
et al
Added:
10 months ago
Eva Prescott
Research Area(s) / Expertise:
Job title: Professor at Bispebjerg Hospital, Department of Cardiology, Copenhagen, Denmark
Author
Juan Carlos Kaski
Job title: Professor of Cardiovascular Science
Author
Author(s):
Mandeep Mehra
,
Christian Inchaustegui
Added:
1 year ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs.
View more
Angela Maas
Author
Author(s):
Joost Daemen
,
Allen Jeremias
,
Ziad A Ali
Added:
1 year ago
Join us for an informative video that explores the innovative approach of performing zero-contrast percutaneous coronary intervention (PCI) using advanced medical technologies and best practices. In recent years, contrast supply shortages and the need for improved patient outcomes have presented significant challenges in care delivery. In this video, our esteemed faculty will demonstrate the…
View more